201 related articles for article (PubMed ID: 11795950)
1. Cyclic AMP in ovarian cancer cells both inhibits proliferation and increases c-KIT expression.
Shaw TJ; Keszthelyi EJ; Tonary AM; Cada M; Vanderhyden BC
Exp Cell Res; 2002 Feb; 273(1):95-106. PubMed ID: 11795950
[TBL] [Abstract][Full Text] [Related]
2. AKT mediates the pro-survival effects of KIT in ovarian cancer cells and is a determinant of sensitivity to imatinib mesylate.
Shaw TJ; Vanderhyden BC
Gynecol Oncol; 2007 Apr; 105(1):122-31. PubMed ID: 17169414
[TBL] [Abstract][Full Text] [Related]
3. Hormonally regulated expression and alternative splicing of kit ligand may regulate kit-induced inhibition of meiosis in rat oocytes.
Ismail RS; Dubé M; Vanderhyden BC
Dev Biol; 1997 Apr; 184(2):333-42. PubMed ID: 9133439
[TBL] [Abstract][Full Text] [Related]
4. Regulatory role of kit ligand-c-kit interaction and oocyte factors in steroidogenesis by rat granulosa cells.
Miyoshi T; Otsuka F; Nakamura E; Inagaki K; Ogura-Ochi K; Tsukamoto N; Takeda M; Makino H
Mol Cell Endocrinol; 2012 Jul; 358(1):18-26. PubMed ID: 22366471
[TBL] [Abstract][Full Text] [Related]
5. Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.
Scappini B; Onida F; Kantarjian HM; Dong L; Verstovsek S; Keating MJ; Beran M
Clin Cancer Res; 2001 Dec; 7(12):3884-93. PubMed ID: 11751479
[TBL] [Abstract][Full Text] [Related]
6. The ligand of the c-kit receptor promotes oocyte growth.
Packer AI; Hsu YC; Besmer P; Bachvarova RF
Dev Biol; 1994 Jan; 161(1):194-205. PubMed ID: 7507447
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta regulates Kit ligand expression in rat ovarian surface epithelial cells.
Ismail RS; Cada M; Vanderhyden BC
Oncogene; 1999 Aug; 18(33):4734-41. PubMed ID: 10467421
[TBL] [Abstract][Full Text] [Related]
8. The Kit ligand/c-Kit receptor system in goat ovaries: gene expression and protein localization.
Silva JR; van den Hurk R; van Tol HT; Roelen BA; Figueiredo JR
Zygote; 2006 Nov; 14(4):317-28. PubMed ID: 17266790
[TBL] [Abstract][Full Text] [Related]
9. Stem cell factor is not essential for cell survival and proliferation of soft tissue sarcoma of neuroectodermal origin.
Ricotti E; Bertorello N; Vai S; Pagani A; Cordero Di Montezemolo L; Madon E; Basso G
Haematologica; 1999 Oct; 84(10):879-86. PubMed ID: 10509034
[TBL] [Abstract][Full Text] [Related]
10. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
[TBL] [Abstract][Full Text] [Related]
11. The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Attoub S; Rivat C; Rodrigues S; Van Bocxlaer S; Bedin M; Bruyneel E; Louvet C; Kornprobst M; André T; Mareel M; Mester J; Gespach C
Cancer Res; 2002 Sep; 62(17):4879-83. PubMed ID: 12208734
[TBL] [Abstract][Full Text] [Related]
12. The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia.
Manova K; Huang EJ; Angeles M; De Leon V; Sanchez S; Pronovost SM; Besmer P; Bachvarova RF
Dev Biol; 1993 May; 157(1):85-99. PubMed ID: 7683286
[TBL] [Abstract][Full Text] [Related]
13. [Effect of tyrosine kinase inhibitor Imatinib mesylate on proliferation, differentiation and apoptosis of Kasumi-1 leukemia cell line].
Wang LH; Rao Q; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2005 Aug; 26(8):449-52. PubMed ID: 16383232
[TBL] [Abstract][Full Text] [Related]
14. Stem cell factor/c-Kit interactions regulate human islet-epithelial cluster proliferation and differentiation.
Li J; Goodyer CG; Fellows F; Wang R
Int J Biochem Cell Biol; 2006; 38(5-6):961-72. PubMed ID: 16213778
[TBL] [Abstract][Full Text] [Related]
15. Kit ligand and c-Kit are expressed during early human ovarian follicular development and their interaction is required for the survival of follicles in long-term culture.
Carlsson IB; Laitinen MP; Scott JE; Louhio H; Velentzis L; Tuuri T; Aaltonen J; Ritvos O; Winston RM; Hovatta O
Reproduction; 2006 Apr; 131(4):641-9. PubMed ID: 16595715
[TBL] [Abstract][Full Text] [Related]
16. Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation.
Ismail RS; Okawara Y; Fryer JN; Vanderhyden BC
Mol Reprod Dev; 1996 Apr; 43(4):458-69. PubMed ID: 9052937
[TBL] [Abstract][Full Text] [Related]
17. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
[TBL] [Abstract][Full Text] [Related]
18. Stem cell factor attenuates vascular smooth muscle apoptosis and increases intimal hyperplasia after vascular injury.
Wang CH; Verma S; Hsieh IC; Hung A; Cheng TT; Wang SY; Liu YC; Stanford WL; Weisel RD; Li RK; Cherng WJ
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):540-7. PubMed ID: 17204664
[TBL] [Abstract][Full Text] [Related]
19. Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells.
Warrenfeltz SW; Lott SA; Palmer TM; Gray JC; Puett D
Mol Cancer Res; 2008 Nov; 6(11):1775-85. PubMed ID: 19010824
[TBL] [Abstract][Full Text] [Related]
20. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
Basciani S; Brama M; Mariani S; De Luca G; Arizzi M; Vesci L; Pisano C; Dolci S; Spera G; Gnessi L
Cancer Res; 2005 Mar; 65(5):1897-903. PubMed ID: 15753388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
